Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High density lipoprotein measurement
|
1440 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.800 | 1.000 | 11 | 2009 | 2019 | ||||
Serum total cholesterol measurement
|
1243 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.800 | 1.000 | 5 | 2010 | 2018 | ||||
C-reactive protein measurement
|
624 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.800 | 1.000 | 4 | 2011 | 2019 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.720 | 1.000 | 4 | 2010 | 2019 | ||||
Serum HDL cholesterol measurement
|
679 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 4 | 2009 | 2013 | ||||
Fibrinogen assay
|
143 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 2 | 2016 | 2017 | ||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||
Alcohol consumption
|
535 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Biliary calculi
|
31 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Blood basophil count (lab test)
|
452 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Coronary heart disease
|
1178 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||
Eosinophil count procedure
|
1144 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Factor VII measurement
|
36 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Granulocyte count
|
150 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Hematocrit procedure
|
216 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Neutrophil count (procedure)
|
234 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Red Blood Cell Count measurement
|
1599 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Uric acid measurement (procedure)
|
1463 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
White Blood Cell Count procedure
|
1322 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Cholecystolithiasis
|
62 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Cholelithiasis
|
90 | 0.851 | 0.160 | 20 | 44413724 | missense variant | C/T | snv | 3.1E-02 | 2.5E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 |